FDA advisors recommend first-ever RSV vaccine from Pfizer, despite possible Guillain-Barre risks
Several FDA advisors said there could be a significant safety issue after two vaccine recipients out of about 20,000 developed
Read More
Pfizer Inc
FDA says Guillain-Barre syndrome is possible risk of Pfizer’s RSV vaccine for older adults
The FDA sees a potential risk and has asked Pfizer to conduct a safety study on Guillain-Barre after a potential
Read More
U.S. plans to stop buying Covid shots for the public this fall. Here’s what that means for you
Under the Affordable Care Act, most Americans would still get their Covid shots for free once the vaccine program goes
Read More
The end of the Covid health emergency won’t slow FDA clearance of shots and treatments
The FDA has used separate emergency powers to authorize the Pfizer, Moderna, Johnson & Johnson and Novavax vaccines. Source link
Read More
UBS downgrades Pfizer, cites lower Covid expectations and a slow pipeline
Pfizer shares are down more than 12% this year on expectations that number and severity of Covid cases will stabilize.
Read More
Stocks making the biggest moves midday: Goldman Sachs, Morgan Stanley, Roblox, Alibaba and more
These are the stocks posting the largest moves in midday trading. Source link
Read More
BioNTech says it will start cancer vaccine trials in the UK from September
The company aims to test 10,000 personalized mRNA therapies, including cancer vaccines, between September 2023 to the end of the
Read More
Rising rates hurt these stocks. They could benefit now if the Fed dials back inflation fight
Bank of America screened for stocks hurt by rising interest rates. If the Fed dials back, they could benefit. Source
Read More
Goldman Sachs upgrades Pfizer, says pharma giant can outperform even as Covid demand diminishes
Advancements in base business are helping quell fears of what will happen in a Covid trough. Source link
Read More